 SAN DIEGO LORDSTOWN, Ohio--BUSINESS WIRE--- KDMN ClassAction--Shareholder rights law firm Robbins LLP announces that a purchaser of Kadmon Holdings, Inc. NASDAQ: KDMN filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between October 1, 2020 and March 10, 2021. Kadmon is a biopharmaceutical company that develops small molecules and biologics primarily for the treatment of inflammatory and fibrotic diseases. Kadmons 